Private Trust Co. NA Has $1.82 Million Stock Position in Zoetis Inc. (NYSE:ZTS)

Private Trust Co. NA cut its stake in shares of Zoetis Inc. (NYSE:ZTSFree Report) by 2.0% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 9,299 shares of the company’s stock after selling 185 shares during the quarter. Private Trust Co. NA’s holdings in Zoetis were worth $1,817,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Darwin Wealth Management LLC acquired a new position in Zoetis in the 3rd quarter worth about $31,000. First Personal Financial Services bought a new stake in shares of Zoetis during the third quarter worth about $33,000. Capital Performance Advisors LLP acquired a new position in shares of Zoetis in the third quarter valued at approximately $33,000. Quarry LP raised its holdings in Zoetis by 273.2% in the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after buying an additional 153 shares during the last quarter. Finally, LRI Investments LLC acquired a new stake in Zoetis during the 1st quarter worth approximately $43,000. 92.80% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Argus upgraded shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Piper Sandler raised their target price on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 14th. Stifel Nicolaus upped their price target on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Wednesday, September 18th. BTIG Research increased their price target on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Finally, JPMorgan Chase & Co. lifted their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Ten research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Zoetis has a consensus rating of “Buy” and an average price target of $221.44.

Get Our Latest Report on Zoetis

Zoetis Stock Up 1.0 %

Shares of NYSE ZTS opened at $178.70 on Tuesday. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The firm has a market cap of $80.62 billion, a PE ratio of 33.59, a P/E/G ratio of 2.71 and a beta of 0.90. The company’s fifty day simple moving average is $185.31 and its 200 day simple moving average is $180.79. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92.

Zoetis (NYSE:ZTSGet Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. During the same quarter in the previous year, the company posted $1.36 earnings per share. The company’s quarterly revenue was up 11.6% on a year-over-year basis. As a group, sell-side analysts forecast that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be issued a dividend of $0.432 per share. This represents a $1.73 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date is Thursday, October 31st. Zoetis’s dividend payout ratio is currently 32.52%.

Zoetis Profile

(Free Report)

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Further Reading

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTSFree Report).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.